Locus for severity implicates CNS resilience in progression of multiple sclerosis
University of California, San Francisco · Karolinska University Hospital · +71 more institutions
Indexed incrossrefdatacitepubmed
Abstract
No abstract available for this paper.
Citation impact
219
total citations
- FWCI
- 53.63
- Percentile
- 100%
- References
- 91
Citations per year
Authors
121- AHAdil HarroudCorresponding
University of California, San Francisco
- PSPernilla Stridh
Karolinska University Hospital, Karolinska Institutet
- JLJacob L. McCauley
University of Miami, Dr. John T. Macdonald Foundation
- JSJanna Saarela
University of Helsinki, University of Oslo, Institute for Molecular Medicine Finland
- AMAletta M.R. van den Bosch
Netherlands Institute for Neuroscience
Topics & keywords
Topics
Keywords
- Multiple sclerosis
- Locus (genetics)
- Neuroscience
- Psychology
- Resilience (materials science)
- Biology
- Genetics
- Gene
No related works found for this paper.
Funding
- NMNational Multiple Sclerosis SocietyAwards: 733161, FAN-1808-32256, JF-1808-32223, RG-1707-28657
- BSBristol-Myers Squibb Foundation
- AAmgen
- BSBristol-Myers Squibb
- ELEli Lilly and Company
- SSanofi
- YUYale University
- BBiogen
- KPKaiser Permanente
- TPTeva Pharmaceutical Industries
- APAlexion Pharmaceuticals
- CCelgene
- HYHelsingin Yliopisto
- RPRegeneron Pharmaceuticals
- TTTG Therapeutics
- RTRace to Erase MS
- IPInternational Progressive MS AllianceAward: PA-1604-08492
- DTDisarm Therapeutics
- MSMultiple Sclerosis Society of CanadaAward: FAN-1808-32256
- NINational Institute for Health and Care Research
- MSMultiple Sclerosis Society
- ECEuropean CommissionAward: 733161
- UOUniversity of Tasmania
- DFDeutsche ForschungsgemeinschaftAwards: TR-128, EXC 2145, ID 390857198, 390857198, CRC-TR-128, EXC 2145 SyNergy
- BFBundesministerium für Bildung und Forschung
- SYSun Yat-sen University
- FWFonds Wetenschappelijk OnderzoekAwards: FWO G.07334.15, G.07334.15, 11ZZZ21N
- MDMinistero della SaluteAward: RF-2016-02361294
- KLKU LeuvenAward: C24/16/045
- KOKnut och Alice Wallenbergs Stiftelse
- MMax-Planck-Gesellschaft
- VVetenskapsrådetAward: 2020-01638
- UDUniversità degli Studi del Piemonte Orientale
- FOForskningsrådet om Hälsa, Arbetsliv och Välfärd
- RERed Española de Esclerosis MúltipleAwards: RD16/0015/0003, RD16/0015/0002
- VRVlaamse regering
- MTMitsubishi Tanabe Pharma Corporation
- MIMenzies Institute for Medical Research
- IPIdorsia Pharmaceuticals
- MSMultiple Sclerosis Society of Western Australia
- NINational Institutes of HealthAwards: R01ES017080, R01NS099240, R01NS049510, RG-1707-28657, R01AI076544, JF-1808-32223
- GGenentech
- ESEMD Serono
- UOUniversity of California, San Francisco
- SGSanofi Genzyme
- NINovartis Institutes for BioMedical Research
- IDInstituto de Salud Carlos IIIAwards: PI15/00587, PI18/01030, RD16/0015/0002, RD16/0015/0003
- EUErasmus Universitair Medisch Centrum Rotterdam
- NCNIHR Cambridge Biomedical Research Centre
- NINational Institute of Neurological Disorders and StrokeAwards: R01NS099240, R01NS049510